BIA
Bell Investment Advisors Portfolio holdings
AUM
$582M
1-Year Return
9.2%
This Quarter Return
+5.22%
1 Year Return
+9.2%
3 Year Return
+27.53%
5 Year Return
–
10 Year Return
–
AUM
$582M
AUM Growth
+$40.4M
(+7.5%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
59.02%
Holding
2,001
New
97
Increased
780
Reduced
418
Closed
122
Top Buys
Top Sells
| 1 |
iShares California Muni Bond ETF
CMF
|
+$3.09M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$1.75M |
| 3 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.66M |
| 4 |
iShares Core 60/40 Balanced Allocation ETF
AOR
|
+$1.19M |
| 5 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$598K |
Sector Composition
| 1 | Technology | 2.86% |
| 2 | Communication Services | 1.16% |
| 3 | Financials | 1.13% |
| 4 | Industrials | 1.09% |
| 5 | Healthcare | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Vitesse Energy
VTS
$999M
| $1.77K | ﹤0.01% |
80
-42
| -34% | -$928 |
|
1402
NOV
NOV
$4.85B
| $1.77K | ﹤0.01% |
142
-58
| -29% | -$721 |
|
1403
FirstService
FSV
$9.32B
| $1.75K | ﹤0.01% |
10
| – | – |
|
1404
Energizer
ENR
$1.94B
| $1.73K | ﹤0.01% |
86
-18
| -17% | -$363 |
|
1405
Pan American Silver
PAAS
$15.3B
| $1.73K | ﹤0.01% |
61
| – | – |
|
1406
Denali Therapeutics
DNLI
$2.14B
| $1.72K | ﹤0.01% |
123
+71
| +137% | +$993 |
|
|
NBIS
1407
Nebius Group N.V. Class A Ordinary Shares
NBIS
$22.3B
| $1.72K | ﹤0.01% |
31
| – | – |
|
1408
Qualys
QLYS
$4.75B
| $1.72K | ﹤0.01% |
12
| – | – |
|
1409
Legend Biotech
LEGN
$6.18B
| $1.7K | ﹤0.01% |
48
-68
| -59% | -$2.41K |
|
1410
RH
RH
$4.29B
| $1.7K | ﹤0.01% |
+9
| New | +$1.7K |
|
1411
Construction Partners
ROAD
$6.95B
| $1.7K | ﹤0.01% |
16
| – | – |
|
1412
StoneCo
STNE
$4.71B
| $1.7K | ﹤0.01% |
106
| – | – |
|
1413
Bio-Rad Laboratories Class A
BIO
$7.49B
| $1.69K | ﹤0.01% |
7
+6
| +600% | +$1.45K |
|
1414
Nice
NICE
$8.77B
| $1.69K | ﹤0.01% |
10
-6
| -38% | -$1.01K |
|
|
PMT
1415
PennyMac Mortgage Investment
PMT
$1.08B
| $1.69K | ﹤0.01% |
131
| – | – |
|
1416
Hudbay
HBM
$5.33B
| $1.68K | ﹤0.01% |
158
| – | – |
|
1417
Novanta
NOVT
$4.14B
| $1.68K | ﹤0.01% |
13
-20
| -61% | -$2.58K |
|
1418
Grupo Aval
AVAL
$4.02B
| $1.68K | ﹤0.01% |
596
| – | – |
|
1419
Axsome Therapeutics
AXSM
$6.19B
| $1.67K | ﹤0.01% |
16
| – | – |
|
1420
GXO Logistics
GXO
$5.76B
| $1.66K | ﹤0.01% |
34
-51
| -60% | -$2.48K |
|
|
ZH
1421
Zhihu
ZH
$449M
| $1.66K | ﹤0.01% |
416
| – | – |
|
1422
AAR Corp
AIR
$2.66B
| $1.65K | ﹤0.01% |
24
| – | – |
|
1423
DiamondRock Hospitality
DRH
$1.72B
| $1.65K | ﹤0.01% |
215
| – | – |
|
1424
LCI Industries
LCII
$2.47B
| $1.64K | ﹤0.01% |
18
+3
| +20% | +$274 |
|
1425
Hexcel
HXL
$4.93B
| $1.64K | ﹤0.01% |
29
-38
| -57% | -$2.15K |
|